Also, recent announcements include a letter of intent to work with deCODE, a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases...BD
DALLAS and NEW YORK, May 6 /PRNewswire/ -- U.S. Preventive Medicine(R), (http://www.uspreventivemedicine.com/) the leader in prevention, today announced the company has selected its investment banking team, composed of Credit Suisse, Deutsche Bank, Merrill Lynch, UBS and Stanford Eagle to coordinate its long term capital strategy, mergers and acquisition efforts in the U.S. and internationally.
U.S. Preventive Medicine(R), a privately owned company, is building the first personalized medicine business in the United States and internationally focused on prevention. The company offers employers, government agencies and consumers proprietary products that include The Prevention Plan(TM), a groundbreaking personalized wellness program delivered online to individuals; The Prevention Plan CM(TM), field-based chronic disease management programs customized for employers and government agencies to reduce healthcare costs; and The Centers for Preventive Medicine(R), which offer high-tech diagnostic screenings delivered to consumers in partnership with hospitals, health systems and other providers
0 comments :
Post a Comment